Davide Mei
@DavideMei93
Followers
141
Following
498
Media
23
Statuses
356
Cardiologist, PhD candidate Modena Univ | Research fellow LCCS Liverpool Univ | Associate #SoMe Editor #Europace | Tweet are my own
Modena, Emilia Romagna
Joined November 2020
Now ONLINE Vascular access & closure management for electrophysiological interventions in 2025: Clinical Consensus Statement #EHRA @escardio @HRSonline 📖 https://t.co/yq10oVCBZk
@GiulioConte9 @FraSantoroMD @marcovitoloMD
@AndyZhangMD @Dominik_Linz @DavideMei93
@LuigiDiBiaseMD
Our consensus document on vascular access for EP procedures is in print! Group effort by #EHRA, #EAPCI and #ESC CV Surgery Working Group. https://t.co/Z1CHFB4afS
1
14
30
⚡️#Europace #Epeeps Impact of #PFA vs radiofrequency on #AFib ablation workflow and organization: a single high volume center experience 📖 https://t.co/778XDEF0Ju
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @LuigiDiBiaseMD
0
13
29
📢 Is the blanking period after #AF ablation needed?👉 https://t.co/SWJyX2GIup
@EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @DavideMei93 #Europace #arrhyhtmias #AF #Europace
2
11
30
📢Check out our latest editorial published in @EuropaceEiC ! From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients 📎 Editorial full text: https://t.co/bju3ZRlM0D
@JacopoImberti @BorianiGiuseppe
academic.oup.com
This editorial refers to ‘Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study’ by
0
4
5
📢#Europace #Epeeps Discordance between #LAP and risk scores in assessment of #HFpEF in patients with AF undergoing catheter ablation 👉 https://t.co/wh4ZA1klCZ
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @LuigiDiBiaseMD
0
13
19
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III #Afib @LHCHFT @LivHPartners
https://t.co/yhxwcJIuvt
0
4
5
🚨 New Controversy out in #Europace! 🫀 The blanking period after AF ablation 🎯 🎙️ Watch the interview between #Europace EiC and EHRA President 👉 Read the Controversy on Europace https://t.co/oYJVcnvOj5
1
13
33
Cardiovascular-kidney-metabolic domains & impact on antithrombotic treatment, integrated care & clinical outcomes in patients with #Afib: results from a prospective European registry Check out our latest paper!🖇️ https://t.co/UQdrQ06V6y
@EJIM_journal @marcovitoloMD @DavideMei93
0
3
5
📢 Check out our latest editorial just published in #Europace! Grateful to have worked with my co-authors on this article 👏 Full text link ⬇️ https://t.co/AVgQrGXCxR
@EuropaceEiC @JacopoImberti @BorianiGiuseppe
academic.oup.com
This editorial refers to ‘Long-Term All-Cause Mortality and Hospitalisations after Catheter Ablation in Patients with Paroxysmal and Persistent Atrial Fibr
🥁#Europace #Epeeps
#AF ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term. 🔗 https://t.co/CM0P915II3
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @LuigiDiBiaseMD
0
3
3
🆕 New paper out in @EJIM_journal : #CKM domains in #AF 📊 >7,700 patients: 93.7% had ≥1 CKM domain ⚠️ More CKM = worse outcomes (death, ACS, thromboembolism) 🩺 ABC pathway adherence = better outcomes 👉 Full text: https://t.co/fD7DOibcIG
@BorianiGiuseppe @LiverpoolCCS
0
2
5
🥁#Europace #Epeeps Impact of Pulse Duration on Cardiac Electroporation: #Nanosecond #PFA favored regulated cell death and cardiomyocyte selectivity 🖨️ https://t.co/KegEYFcfTr
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @LuigiDiBiaseMD
0
10
29
🥁#Europace #Epeeps
#AF ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term. 🔗 https://t.co/CM0P915II3
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @LuigiDiBiaseMD
2
11
25
📣#Europace #Epeeps 🤔Conduction system pacing vs. biventricular pacing for cardiac resynchronization❓ ✅Check this randomized study! 🔗 https://t.co/dAcEO1UNwU
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz @DavideMei93 @LuigiDiBiaseMD
1
23
54
📣 Live from #ESCCongress2025 in Madrid 📺 Watch the interview by @DavideMei93 with Prof. Boersma on the results of the FARADISE Registry just published on #Europace 📚Read the full article https://t.co/All3pSCPsP ✒️ Editorial https://t.co/f0vwljG6dU
0
7
13
📢 Simultaneous publication at the #ESCCongress2025 now out in #Europace Prof Lucas Boersma presented the results of the FARADISE registry on 1-year outcome of pulsed field ablation in AF patients Chek out the results and the full open access text 🔗 https://t.co/W79NsHqA55
1
2
9
🚨 Simultaneous #ESCCongress2025 publication! ⚡️FARADISE Global Registry: 1-year clinical effectiveness of PFA for AF Presented by Prof. Lucas Boersma 📊See full results 👉 https://t.co/All3pSCPsP 📚Read the accompanying editorial https://t.co/YDvEGRTpnx
1
22
50
Is LBBAP suitable for patients of all ages? It definitely seems so in middle-aged adults. Take 5 minutes to read our new article. https://t.co/sNLOpnBw1X
@Fra_Vitali90 @lucacanov @JacopoImberti @DavideMei93 @cristinaballa1
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
4
11
Multimorbidity & fraility have a clear definition, prognostic implication and should be managed wisely! Enlightening talk by @GiulioFRomiti 👏 #ESCCongress2025
@LiverpoolCCS @simovicst @tanjapotpara1 @JacopoImberti @L_Bergamaschi @Fra_Vitali90
0
11
23
Mutimorbidity, fraility & #Afib Join us in Paris! The session starts in 5min! ⏰ @LiverpoolCCS @EHRAPresident @GiulioFRomiti @simovicst
0
1
6
📣 Live from #ESCCongress2025 in Madrid: @EuropaceEiC and @joselmerino talking on the new EHRA Practical Compendium on AADs 🫀✨ 📚A must-read for clinicians in arrhythmia management! Read the full paper 🔗 https://t.co/F6aqqDRNbF
#Europace #EPeeps
@EHRAPresident @escardio
2
21
48